Drug Profile


Alternative Names: ddI/HU - Virostatics; Didanosine/hydroxyurea - Virostatics; VS 411

Latest Information Update: 04 Mar 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Virostatics
  • Class Antianaemics; Antineoplastics; Antiretrovirals; Dideoxynucleosides; Purine nucleosides; Ribonucleosides; Urea compounds
  • Mechanism of Action DNA synthesis inhibitors; Nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 02 Mar 2011 Discontinued - Phase-II for HIV-1 infections in Argentina, Uganda, Russia and Italy (PO)
  • 02 Mar 2011 Efficacy data from a phase II trial in HIV-1 infections released by Virostatics
  • 19 Jul 2010 Efficacy and adverse events data from a phase II trial in HIV-1 infections presented at the 18th International AIDS Conference (IAC-2010)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top